Epidemiology and Natural History of Benign Prostatic Hyperplasia

Abrams, 1977, A double-blind trial of the effects of Candicidin on patients with benign prostatic hypertrophy, Br J Urol, 49, 67, 10.1111/j.1464-410X.1977.tb04526.x

Abrams, 1979, The results of prostatectomy: A symptomatic and urodynamic analysis of 152 patients, J Urol, 121, 640, 10.1016/S0022-5347(17)56918-9

Abrams, 1982, Bladder outflow obstruction treated with phenoxybenzamine, Br J Urol, 54, 527, 10.1111/j.1464-410X.1982.tb13581.x

Andersen, 1979, Prostatism I: The correlation between symptoms, cystometric and urodynamic findings, Scand J Urol Nephrol, 13, 229, 10.3109/00365597909179530

Andersen, 1982, Prostatism III: Detrusor hyperreflexia and residual urine: Clinical and urodynamic aspects and influence of surgery on the prostate, Scand J Urol Nephrol, 16, 25, 10.3109/00365598209179636

Araki, 1983, High-risk group for benign prostatic hypertrophy, Prostate, 4, 253, 10.1002/pros.2990040305

Ashley, 1966, Observations on the epidemiology of prostatic hyperplasia in Wales, Br J Urol, 38, 567, 10.1111/j.1464-410X.1966.tb09755.x

Ball, 1981, The natural history of untreated “prostatism.”, Br J Urol, 53, 613, 10.1111/j.1464-410X.1981.tb03273.x

Barnes, 1983, Progression of obstruction and symptoms, 712

Beck, 1970, Benign prostatic hypertrophy and uraemia: A review of 315 cases, Br J Surg, 57, 561, 10.1002/bjs.1800570803

Bennet, 1950, The testis, breast and prostate of men who die of cirrhosis of the liver, Am J Clin Pathol, 20, 814, 10.1093/ajcp/20.9.814

Berry, 1984, The development of human benign prostatic hyperplasia with age, J Urol, 132, 474, 10.1016/S0022-5347(17)49698-4

Birkhoff, 1976, Natural history of benign prostatic hypertrophy and acute urinary retention, Urology, 7, 48, 10.1016/0090-4295(76)90560-4

Bourke, 1966, Hypertension, diabetes mellitus, and blood groups in benign prostatic hypertrophy, Br J Urol, 38, 18, 10.1111/j.1464-410X.1966.tb09675.x

Breum, 1982, Significance of acute urinary retention due to infravesical obstruction, Scand J Urol Nephrol, 16, 21, 10.3109/00365598209179635

Caine, 1978, A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction, Br J Urol, 50, 551, 10.1111/j.1464-410X.1978.tb06210.x

Castro, 1971, A double-blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophy, Br J Surg, 58, 485, 10.1002/bjs.1800580703

Chang, 1936, Benign hypertrophy of the prostate, Chin Med J, 50

Chassin, 1986, Variations in the use of medical and surgical services by the Medicare population, N Engl J Med, 314, 285, 10.1056/NEJM198601303140505

Clarke, 1937, The prostate and the endocrines: A control series, Br J Urol, 9, 254, 10.1111/j.1464-410X.1937.tb06620.x

Craigen, 1969, Natural history of prostatic obstruction, J R Coll Gen Pract, 18, 226

D'Aunoy, 1939, The relative incidence of hyperplasia of the prostate in the white and colored races in Louisiana, South Med J, 32, 47, 10.1097/00007611-193901000-00009

Derbes, 1937, The incidence of benign prostatic hypertrophy among the whites and Negroes in New Orleans, J Urol, 38, 383, 10.1016/S0022-5347(17)71966-0

Dorflinger, 1985, The significance of uninhibited detrusor contractions in prostatism, J Urol, 133, 819, 10.1016/S0022-5347(17)49240-8

Dowd, 1961, Silent prostatism (unrecognized bladder neck obstruction), JAMA, 178, 142, 10.1001/jama.1961.03040420036008

Fay, 1983, Prostatic obstruction in Chinese populations, 27

Ferrie, 1987, Phenoxybenzamine in prostatic hypertrophy: A double-blind study, Br J Urol, 59, 63, 10.1111/j.1464-410X.1987.tb04581.x

Fletcher, 1982

Fowler, 1988, Symptom status and quality of life following prostatectomy, JAMA, 259, 10.1001/jama.1988.03720200040030

Franks, 1954, Benign nodular hyperplasia of the prostate: A review, Ann R Coll Surg, 14, 92

Frea, 1987, Correlation between liver cirrhosis and benign prostatic hyperplasia: A morphological study, Urol Res, 15, 311, 10.1007/BF00258203

Friedman, 1980

Frimodt-Møller, 1984, Analysis of presenting symptoms in prostatism, J Urol, 132, 272, 10.1016/S0022-5347(17)49587-5

Geller, 1979, Effect of megestrol acetate on uroflow rates in patients with benign prostatic hypertrophy, Urology, 14, 467, 10.1016/0090-4295(79)90177-8

Gilpin, 1985, Morphologic and morphometric studies of the human obstructed trabeculated bladder, Br J Urol, 57, 525, 10.1111/j.1464-410X.1985.tb05860.x

Glynn, 1985, The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study, Am J Epidemiol, 121, 78

Gosling, 1980, Structure of trabeculated detrusor smooth muscle in cases of prostatic hypertrophy, Urol Int, 35, 351, 10.1159/000280347

Graversen, 1989, Controversies about indications for transurethral resection of the prostate, J Urol, 141, 475, 10.1016/S0022-5347(17)40864-0

Graves, 1989, Detailed diagnoses and procedures, National Hospital Discharge Survey: 1987, Natl Center Health Stat Vital Health Stat, 13, 295

Greenwald, 1971, Vaginal cancer after maternal treatment with synthetic estrogens, N Engl J Med, 285, 390, 10.1056/NEJM197108122850707

Harbitz, 1972, Histology of the prostate in elderly men: A study in an autopsy series, Acta Pathol Microbiol Scand [A], 80, 756

Hayden, 1982, The casecontrol study: A practical review for the clinician, JAMA, 247, 326, 10.1001/jama.1982.03320280046028

Hedlund, 1983, Effects of prazosin in patients with benign prostatic obstruction, J Urol, 130, 275, 10.1016/S0022-5347(17)51106-4

Herbst, 1971, Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women, N Engl J Med, 284, 878, 10.1056/NEJM197104222841604

Jensen, 1983, Candicidin treatment of prostatism: A prospective double-blind placebo-controlled study, Urol Res, 11, 7, 10.1007/BF00272701

Jensen, 1986, Some clinical aspects of uroflowmetry in elderly males, Scand J Urol Nephrol, 20, 93, 10.3109/00365598609040555

Kambal, 1977, Prostatic obstruction in Sudan, Br J Urol, 49, 139, 10.1111/j.1464-410X.1977.tb04086.x

Kirby, 1987, Prazosin in the treatment of prostatic obstruction, Br J Urol, 60, 136, 10.1111/j.1464-410X.1987.tb04950.x

Lytton, 1968, The incidence of benign prostatic obstruction, J Urol, 99, 639, 10.1016/S0022-5347(17)62763-0

Madsen, 1984, Candicidin in treatment of benign prostatic hypertrophy, J Urol, 132, 10.1016/S0022-5347(17)50112-3

McFarlane, 1986, Diethylstilbestrol and clear cell vaginal carcinoma, Am J Med, 81, 855, 10.1016/0002-9343(86)90358-X

McPherson, 1982, Small-area variations in the use of common surgical procedures: An international comparison of New England, England and Norway, N Engl J Med, 307, 10.1056/NEJM198211183072104

Mebust, 1989, Transurethral prostatectomy: Immediate and postoperative complications: A cooperative study of 13 participating institutions evaluating 3,885 patients, J Urol, 141, 243, 10.1016/S0022-5347(17)40731-2

Miettinen, 1985

Moore, 1943, Benign hypertrophy of the prostate: A morphological study, J Urol, 50, 680, 10.1016/S0022-5347(17)70503-4

Morrison, 1978, Prostatic hypertrophy in greater Boston, J Chron Dis, 31, 357, 10.1016/0021-9681(78)90052-8

Mukamel, 1979, Occult progressive renal damage in the elderly male due to benign prostatic hypertrophy, J Am Geriatr Soc, 27, 403, 10.1111/j.1532-5415.1979.tb01676.x

Pradhan, 1975, Morphogenesis of nodular hyperplasia-prostate, J Urol, 113, 210, 10.1016/S0022-5347(17)59446-X

Reece-Smith, 1986, The value of Permixon in benign prostatic hypertrophy, Br J Urol, 58, 36, 10.1111/j.1464-410X.1986.tb05424.x

Resnick, 1983, Assessment of the antihypercholesterolemic drug, Probucol, in benign prostatic hyperplasia, J Urol, 129, 206, 10.1016/S0022-5347(17)51985-0

Roberts, 1966, The role of diabetogenic hyperinsulinism in the pathogenesis of prostatic hyperplasia and malignancy, J Am Geriatr Soc, 14, 795, 10.1111/j.1532-5415.1966.tb02912.x

Robson, 1964, The incidence of benign prostatic hypertrophy and prostatic carcinoma in cirrhosis of the liver, J Urol, 92, 307, 10.1016/S0022-5347(17)63955-7

Rothman, 1986

Rotkin, 1976, Epidemiology of benign prostatic hypertrophy: Review and speculations, 105

Rotkin, 1983, Origins, distribution, and risk of benign prostatic hypertrophy, 10

Sackett, 1985

Sarmina, 1989, Obstructive uropathy in patients with benign prostatic hyperplasia, J Urol, 141, 866, 10.1016/S0022-5347(17)41035-4

Spiro, 1974, Prostatic infarction: Role in acute urinary retention, Urology, 3, 345, 10.1016/S0090-4295(74)80119-6

Sporer, 1975, Candicidin: Physiologic effect on prostate, Urology, 6, 298, 10.1016/0090-4295(75)90750-5

Stumpf, 1953, Inhibitory effects of portal cirrhosis of liver on prostatic enlargement, Arch Intern Med, 91, 304, 10.1001/archinte.1953.00240150023003

Swyer, 1944, Post-natal growth changes in the human prostate, J Anat, 78, 130

Taube, 1989, Trial without catheter following acute retention of urine, Br J Urol, 63, 180, 10.1111/j.1464-410X.1989.tb05160.x

Tugwell, 1981, How to read clinical journals III: To learn the clinical course and prognosis of disease, Can Med Assoc J, 124, 869

US Bureau of the Census, 1989, 13

Watanabe, 1984, A mobile mass screening unit for prostatic disease, Prostate, 5, 559, 10.1002/pros.2990050511

Wennberg, 1982, Variations in medical care among small areas, Sci Am, 246, 120, 10.1038/scientificamerican0482-120

Wennberg, 1982, Professional uncertainty and the problem of supplier-induced demand, Soc Sci Med, 16, 811, 10.1016/0277-9536(82)90234-9